Dr. Taehyun Roh has a broad background in environmental health, with specific training and expertise in toxicology and epidemiology. His current research focus is epidemiological studies of the chronic health effects of drinking water contaminants including arsenic. His earlier research topics include mechanistic toxicological studies across in vitro/in vivo experiments, and exposure and risk assessment of environmental contaminants. He is a Registered Pharmacist in Korea.
- University of California, Berkeley - (Berkeley, California, United States), Postdoctoral Training 2019
- Ph.D. in Human Toxicology, University of Iowa - (Iowa City, Iowa, United States) 2016
- M.Sc. in Pharmacy, Sungkyunkwan University - (Seoul, South Korea) 2010
- B.Pharm. in Pharmacy, Sungkyunkwan University - (Seoul, South Korea) 2008
- Kwack, S. J., Kim, D. Y., Kim, Y. J., Roh, T. H., Choi, S. M., Lim, D. S., ... Lee, B. (2014). Potential Application of Benzo(a)Pyrene-Associated Adducts (Globin or Lipid) as Blood Biomarkers for Target Organ Exposure and Human Risk Assessment. J Toxicol Environ Health A. 77(22-24), 1491-1501.
- Lim, S. K., Shin, H. S., Yoon, K. S., Kwack, S. J., Um, Y. M., Hyeon, J. H., ... Lee, B. (2014). Risk Assessment of Volatile Organic Compounds Benzene, Toluene, Ethylbenzene, and Xylene (BTEX) in Consumer Products. J Toxicol Environ Health A. 77(22-24), 1502-1521.
- Kwack, S. J., Do, S., Kim, Y. W., Kim, Y., Gwak, H., Park, H. J., ... Lee, B. (2014). The No-Observed-Adverse-Effect Level (NOAEL) of Baby Aloe Powder (BAP) for Nutraceutical Application Based Upon Toxicological Evaluation. J Toxicol Environ Health A. 77(22-24), 1319-1331.
- KYUNG, M., KIM, Y. W., ROH, T. H., KIM, M. J., Yoon, A. N., CHUNG, B. Y., ... LEE, B. (2012). Methionine inhibits benzo(a)pyrene-DNA adducts formation in human hepatocellular carcinoma HepG2 cells. ap-126.
- Roh, T., Kwak, M. Y., Kwak, E. H., Kim, D. H., Han, E. Y., Bae, J. Y., ... Lee, B. M. (2012). Chemopreventive mechanisms of methionine on inhibition of benzo(a)pyrene–DNA adducts formation in human hepatocellular carcinoma HepG2 cells. TOXICOLOGY LETTERS. 208(3), 232-238.